Article

Bausch + Lomb files for initial public offering

Bausch + Lomb has filed a registration statement with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock.

Rochester, NY-Bausch + Lomb has filed a registration statement with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission, but has not yet become effective. The number of shares to be offered and the price range for the proposed offering have not yet been determined.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.